Suppr超能文献

保护线粒体:线粒体自噬和线粒体衍生囊泡的途径。

Defending the mitochondria: The pathways of mitophagy and mitochondrial-derived vesicles.

作者信息

Roberts Rosalind F, Tang Matthew Y, Fon Edward A, Durcan Thomas M

机构信息

Centre for Neurodegenerative Disease, Montreal Neurological Institute, McGill University, MP038, Molson Fieldhouse, 3801 Rue University, Montréal, Quebec H3A 2B4, Canada.

Centre for Neurodegenerative Disease, Montreal Neurological Institute, McGill University, MP038, Molson Fieldhouse, 3801 Rue University, Montréal, Quebec H3A 2B4, Canada.

出版信息

Int J Biochem Cell Biol. 2016 Oct;79:427-436. doi: 10.1016/j.biocel.2016.07.020. Epub 2016 Jul 19.

Abstract

Mitochondria are the powerhouses for the cell, consuming oxygen to generate sufficient energy for the maintenance of normal cellular processes. However, a deleterious consequence of this process are reactive oxygen species generated as side-products of these reactions. As a means to protect mitochondria from damage, cells and mitochondria have developed a wide-range of mitochondrial quality control mechanisms that remove damaged mitochondrial cargo, enabling the mitochondria to repair the damage and ultimately restore their normal function. If the damage is extensive and mitochondria can no longer be repaired, a process termed mitophagy is initiated in which the mitochondria are directed for autophagic clearance. Canonical mitophagy is regulated by two proteins, PINK1 and Parkin, which are mutated in familial forms of Parkinson's disease. In this review, we discuss recent work elucidating the mechanism of PINK1/Parkin-mediated mitophagy, along with recently uncovered PINK1/Parkin-independent mitophagy pathways. Moreover, we describe a novel mitochondrial quality control pathway, involving mitochondrial-derived vesicles that direct distinct and damaged mitochondrial cargo for degradation in the lysosome. Finally, we discuss the association between mitochondrial quality control, cardiac, hepatic and neurodegenerative disease and discuss the possibility of targeting these pathways for therapeutic purposes.

摘要

线粒体是细胞的能量工厂,消耗氧气以产生足够的能量来维持正常的细胞过程。然而,这一过程的一个有害后果是作为这些反应的副产物产生的活性氧。作为保护线粒体免受损伤的一种手段,细胞和线粒体已经发展出多种线粒体质量控制机制,这些机制可以清除受损的线粒体物质,使线粒体能够修复损伤并最终恢复其正常功能。如果损伤广泛且线粒体无法再修复,就会启动一个称为线粒体自噬的过程,在此过程中线粒体被引导进行自噬清除。典型的线粒体自噬由两种蛋白质PINK1和Parkin调节,它们在帕金森病的家族形式中发生突变。在这篇综述中,我们讨论了阐明PINK1/Parkin介导的线粒体自噬机制的最新研究,以及最近发现的不依赖PINK1/Parkin的线粒体自噬途径。此外,我们描述了一种新的线粒体质量控制途径,该途径涉及线粒体衍生的囊泡,这些囊泡将不同的受损线粒体物质导向溶酶体进行降解。最后,我们讨论了线粒体质量控制与心脏、肝脏和神经退行性疾病之间的关联,并探讨了针对这些途径进行治疗的可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验